RELMADA THERAPEUTICS, INC. — Director's Dealing 2021

Sep 24, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RELMADA THERAPEUTICS, INC. (RLMD)
CIK: 0001553643
Period of Report: 2021-09-22

Reporting Person: CASAMENTO CHARLES J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-22	Common Stock	M	10000	$4.60	Acquired	16600	Direct
2021-09-22	Common Stock	S	1900	$29	Disposed	14700	Direct
2021-09-22	Common Stock	S	3300	$29	Disposed	11400	Direct
2021-09-22	Common Stock	S	1400	$29	Disposed	10000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-22	Options to purchase common stock	$3.24	M	1900	Disposed	2027-10-20	Common Stock (1900)	Direct

Footnotes

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020.

F2: The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period..

F3: Not applicable